Uploaded April 2026 | Updated September 2026, 54 minutes ago
In his Front Row lecture, President and CEO Pete Schultz highlights the progress Scripps Research has made in pioneering a new model for non-profit biomedical research. He describes how integrating basic science and translational research under one roof is accelerating next-generation medicines—from new immunotherapies for cancer and innovative medicines for infectious disease to regenerative treatments for heart, lung, and intestinal tissues.
At a time of uncertainty in federal science funding, this model is not only advancing human health but also helping to generate sustainable support for innovative scientific research and for training the next generation of scientific leaders.
https://www.scripps.edu/
In his Front Row lecture, President and CEO Pete Schultz highlights the progress Scripps Research has made in pioneering a new model for non-profit biomedical research. He describes how integrating basic science and translational research under one roof is accelerating next-generation medicines—from new immunotherapies for cancer and innovative medicines for infectious disease to regenerative treatments for heart, lung, and intestinal tissues.
At a time of uncertainty in federal science funding, this model is not only advancing human health but also helping to generate sustainable support for innovative scientific research and for training the next generation of scientific leaders.
https://www.scripps.edu/
